Hepatocellular Carcinoma   

Questions discussed in this category

The patient already received PLADO+sorafenib, Y90, and Atezolizumab/Bevacizumab complicated by recurrent episodes of bleeding from esophageal varices....

Would you offer liver transplant in the setting of metastatic disease? 

What parameters do you use to decide to treat beyond progression? Is there any efficacy data from this specific study subgroup in IMbrave150?

In light of the SIRveNIB trial results and now IMbrave150, what is the role of intra-arterial therapy now?

Papers discussed in this category

N Engl J Med, 2020 May 14

Liver Cancer, 2019 Sep 18

The New England journal of medicine, 2018-07-05

Lancet (London, England), 2018-03-24

J Gastroenterol, 2019 Nov 12

Am Heart J, 2010 Sep 18

N Engl J Med,

Lancet (London, England), 2017-01-07

The Lancet. Oncology, 2019-02

JAMA Oncol, 2020 Dec 10

Hepatology, 2019 Oct 14

NEJM Evidence, 2022 June 6

Br J Cancer, 2021 Feb 03

Hepatogastroenterology, 2013 Jan 16

Medicine (Baltimore),